id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-269143-8j3m03gc	Brindisi, Giulia	Pills to think about in allergic rhinitis children during COVID‐19 era	2020-07-05		.txt	text/plain	632	39	45	Allergic rhinitis (AR) is a common pediatric disease, that involves up to the 25% of children worldwide. As described previously in the literature, novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection in children is uncommon and often asymptomatic or mild. As described previously in the literature, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children is uncommon and often asymptomatic or mild 1 . So far, we do not have data demonstrating a higher risk in the development of Coronavirus disease-19 (COVID-19) in allergic children, except for those with uncontrolled symptoms. This could help to detect affected children even with mild symptoms and limit SARS-CoV2 transmission. Instead it can be continued, as usual, in allergic children without clinical symptoms of COVID-19 and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement	./cache/cord-269143-8j3m03gc.txt	./txt/cord-269143-8j3m03gc.txt